Asset Dedication, LLC - SPDR SER TR ownership

SPDR SER TR's ticker is SPAB and the CUSIP is 78464A649. A total of 392 filers reported holding SPDR SER TR in Q3 2023. The put-call ratio across all filers is 0.13 and the average weighting 1.0%.

Quarter-by-quarter ownership
Asset Dedication, LLC ownership history of SPDR SER TR
ValueSharesWeighting
Q3 2023$209
-3.7%
8,5770.0%0.02%
-5.3%
Q2 2023$217
-1.8%
8,5770.0%0.02%
-5.0%
Q1 2023$221
+2.8%
8,5770.0%0.02%
-9.1%
Q4 2022$215
-99.9%
8,5770.0%0.02%
-4.3%
Q3 2022$214,000
+11.5%
8,577
+17.4%
0.02%
-20.7%
Q2 2022$192,000
-2.0%
7,307
+3.7%
0.03%
+31.8%
Q1 2022$196,000
+8.9%
7,045
+15.2%
0.02%0.0%
Q4 2021$180,000
-1.1%
6,113
+0.1%
0.02%
-8.3%
Q3 2021$182,000
-0.5%
6,1090.0%0.02%
-11.1%
Q2 2021$183,000
+2.8%
6,109
+1.4%
0.03%
-32.5%
Q1 2021$178,000
-19.1%
6,024
-15.9%
0.04%
-9.1%
Q4 2020$220,000
+1.9%
7,162
+2.0%
0.04%
-8.3%
Q3 2020$216,0000.0%7,020
+0.6%
0.05%
-18.6%
Q2 2020$216,000
+2.9%
6,9780.0%0.06%
-4.8%
Q1 2020$210,000
-3.2%
6,978
-5.9%
0.06%
+1.6%
Q4 2019$217,000
+0.9%
7,416
+1.7%
0.06%
-14.1%
Q3 2019$215,000
+1.4%
7,2910.0%0.07%
+4.4%
Q2 2019$212,000
-3.6%
7,291
-5.8%
0.07%
-11.7%
Q1 2019$220,000
-10.9%
7,736
-13.0%
0.08%
-23.8%
Q4 2018$247,000
+8.8%
8,888
+8.4%
0.10%
+18.8%
Q3 2018$227,000
+78.7%
8,201
+80.6%
0.08%
+97.7%
Q2 2018$127,000
+693.8%
4,542
+711.1%
0.04%
+437.5%
Q1 2018$16,0000.0%5600.0%0.01%
+33.3%
Q4 2017$16,0005600.01%
Other shareholders
SPDR SER TR shareholders Q3 2023
NameSharesValueWeighting ↓
Bull Oak Capital, LLC 512,411$12,472,08813.64%
McNamara Financial Services, Inc. 2,057,437$50,078,01212.50%
RESTON WEALTH MANAGEMENT LLC 1,002,791$24,407,92912.32%
Willow Creek Wealth Management Inc. 3,135,494$76,317,93711.36%
KWB Wealth 2,757,296$69,952,61211.22%
Leading Edge Financial Planning LLC 612,567$14,909,8749.55%
Beaumont Capital Management, LLC 535,287$13,028,8869.39%
AIFG Consultants Ltd. 443,530$10,795,5298.95%
Trinity Wealth Management, LLC 586,867$14,284,3348.86%
Great Lakes Retirement, Inc. 1,965,244$47,834,0298.62%
View complete list of SPDR SER TR shareholders